Increased healthcare expenditure, rising awareness, advancement in the diagnostics techniques such as enzyme immunoassays (EIA) and polymerase chain reaction (PCR), affordability of diagnostics devices and kits and rapid diagnostics tests are the major drivers for the vibrio diagnostics market in the coming years. Growing peri-urban slums, uncooked and raw seafood intake, inadequacy of clean water and improper sanitation, unhygienic living conditions are the important factors for the growth of cholera and other diseases during the forecast period. Favorable living environment for the bacteria due to the global warming is considered to be the other important factor leading to the growth of diseases thereby leading to the growth of vibrio diagnostics market. Vibrio bacteria are mostly found in estuarine and marine environment. To some extent they are also available in the freshwater environment and are usually found in subtropic and temperate waters. Various species of vibrio causes seafood borne illness such as wound infections and septicaemia. There are almost dozen of species that can cause diseases in humans and accounted for 100 deaths, 500 hospitalizations and 80,000 illnesses in the U.S every year.
Vibrio diagnostics market is segmented into technology and end users. Technology has been further classified into PCR, monoclonal antibodies, flow cytometry, enzyme immunoassays (EIA), diagnostic imaging, immunoprecipitation, Fluorescent immunoassays and immune-PCR. End-users of vibrio diagnostics market includes hospitals, Public Health Laboratories, Private diagnostic labs and commercial diagnostic labs
Geographically, Vibrio diagnostics market is studied with respect to four regions as North America, Europe, RoW and Asia Pacific. Recently, new variant strains have been identified in some parts of Africa and Asia and according to the observations they are expected to cause severe cholera with increasing cases of fatality rates. Inadequate environmental management in the growing economies of Asia Pacific such as India and China owing to the rising population and pollution is expected to drive the vibrio diagnostics market during the forecast period. According to CDC, there is an average of 16 deaths, 45 hospitalizations and 50 confirmed cases along the Gulf Coast each year.
Some of the key players in this market are Dickinson and Company, Lonza Group, Abbott Laboratories, DiamedixImpex S.A., Novartis Diagnostics, Kreatech Holding BV, F. Hoffmann-La Roche Ltd, Fujirebio Diagnostics Inc., Becton and Eiken Chemical Co. Ltd.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.